Please assess the completion status of the following clinical trial:

Trial Title: Multimodal Uterotonics at the Time of Cesarean Section in Laboring Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age~* Laboring patients who undergo a cesarean section~Exclusion Criteria:~* Placenta/Uterine Abnormalities~* Chronic Hypertension, Gestational Hypertension, Preeclampsia~* HIV/AIDS on protease inhibitors~* History of Coronary Artery Disease~* History of Hypersensitivity to Methylergonovine

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Methylergonovine 0.2 mg (Type: EXPERIMENTAL): Standard Oxytocin Infusion at the time of Cesarean Section plus 0.2 mg of Intramuscular Methergine
- Placebo (Normal Saline) (Type: PLACEBO_COMPARATOR): Standard Oxytocin Infusion at the time of Cesarean Section plus 1 milliliter (mL)of normal saline given intramuscular

Based on this trial design, predict the completion outcome and termination type (if applicable).